{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:05:24Z","timestamp":1782317124176,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1626,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Council of the Hong Kong Special Administrative Region","award":["HKU 763211"],"award-info":[{"award-number":["HKU 763211"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ajpath.2015.03.011","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T08:46:21Z","timestamp":1434617181000},"page":"2038-2048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K\/Akt Signaling"],"prefix":"10.1016","volume":"185","author":[{"given":"Victor C.Y.","family":"Mak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar G.W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle K.Y.","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther S.Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Yan","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Kui","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hextan Y.S.","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie N.Y.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2015.03.011_bib1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1521-6934(03)00094-4","article-title":"Pathology of gestational trophoblastic diseases","volume":"17","author":"Cheung","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1470-2045(07)70204-8","article-title":"Gestational trophoblastic neoplasia\u2013pathogenesis and potential therapeutic targets","volume":"8","author":"Shih Ie","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib3","series-title":"Blaustein's Pathology of the Female Genital Tract","first-page":"1193","article-title":"Gestational trophoblastic disease and related lesions","author":"Shih","year":"2002"},{"key":"10.1016\/j.ajpath.2015.03.011_bib4","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.2353\/ajpath.2010.091263","article-title":"p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease","volume":"176","author":"Siu","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/14796694.5.2.217","article-title":"Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives","volume":"5","author":"Cheung","year":"2009","journal-title":"Future Oncol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2559.2001.01065.x","article-title":"Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody","volume":"38","author":"Chiu","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.ajpath.2015.03.011_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2559.2003.01728.x","article-title":"Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathological parameters","volume":"43","author":"Xue","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.ajpath.2015.03.011_bib8","first-page":"223","article-title":"Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas","volume":"39","author":"Cheung","year":"1994","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ajpath.2015.03.011_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/modpathol.2010.216","article-title":"Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome","volume":"24","author":"Mak","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/PGP.0b013e3181de3068","article-title":"Overexpression of the Parkinson disease protein DJ-1 and its regulator PTEN in gestational trophoblastic disease","volume":"29","author":"Zhang","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib11","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/carcin\/bgt161","article-title":"Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation","volume":"34","author":"Mak","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2015.03.011_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/bfgp\/elm002","article-title":"Functional analysis of the role of POK transcriptional repressors","volume":"6","author":"Costoya","year":"2007","journal-title":"Brief Funct Genomic Proteomic"},{"key":"10.1016\/j.ajpath.2015.03.011_bib13","doi-asserted-by":"crossref","first-page":"8575","DOI":"10.1158\/0008-5472.CAN-05-1055","article-title":"The transcription factor Pokemon: a new key player in cancer pathogenesis","volume":"65","author":"Maeda","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.03.011_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature03203","article-title":"Role of the proto-oncogene Pokemon in cellular transformation and ARF repression","volume":"433","author":"Maeda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.03.011_bib15","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1074\/jbc.M809794200","article-title":"Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1","volume":"284","author":"Choi","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.03.011_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.2222","article-title":"Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer","volume":"213","author":"Apostolopoulou","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/1476-4598-9-318","article-title":"Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers","volume":"9","author":"Jiang","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2015.03.011_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/ng.2654","article-title":"Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion","volume":"45","author":"Wang","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2015.03.011_bib19","first-page":"881","article-title":"Gestational trophoblastic disease. Robboy's Pathology of the Female Reproductive Tract","author":"Cheung","year":"2009"},{"key":"10.1016\/j.ajpath.2015.03.011_bib20","first-page":"1359","article-title":"Gestational trophoblastic disease. Haines and Taylor: Obstetrical and Gynaecological Pathology","author":"Paradinas","year":"2003"},{"key":"10.1016\/j.ajpath.2015.03.011_bib21","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/cncr.20107","article-title":"Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis","volume":"100","author":"Cheung","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2015.03.011_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/modpathol.3800010","article-title":"Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization","volume":"17","author":"Lai","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib23","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jsgi.2005.02.008","article-title":"Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1)","volume":"12","author":"Feng","year":"2005","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.ajpath.2015.03.011_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2559.2008.03089.x","article-title":"Activated Stat3 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and apoptotic indices","volume":"53","author":"Chan","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.ajpath.2015.03.011_bib25","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2353\/ajpath.2008.080288","article-title":"Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome","volume":"173","author":"Siu","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib26","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/onc.2012.363","article-title":"Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers","volume":"32","author":"Siu","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2015.03.011_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbrc.2008.09.094","article-title":"LY294002 inhibits leukemia cell invasion and migration through early growth response gene 1 induction independent of phosphatidylinositol 3-kinase-Akt pathway","volume":"377","author":"Liu","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2015.03.011_bib28","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2015.03.011_bib29","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer: variations on a theme","volume":"27","author":"Yuan","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2015.03.011_bib30","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Hennessy","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajpath.2015.03.011_bib31","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1073\/pnas.0604628103","article-title":"Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN","volume":"103","author":"Taniguchi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.03.011_bib32","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)","volume":"269","author":"Vlahos","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.03.011_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humupd\/dml048","article-title":"Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts","volume":"13","author":"Ferretti","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajpath.2015.03.011_bib34","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2217\/fon.10.153","article-title":"Genetics of gestational trophoblastic neoplasia: an update for the clinician","volume":"6","author":"Alifrangis","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.cco.0000198021.99347.b9","article-title":"Oncogenic PI3K and its role in cancer","volume":"18","author":"Samuels","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ajpath.2015.03.011_bib36","doi-asserted-by":"crossref","first-page":"e51916","DOI":"10.1371\/journal.pone.0051916","article-title":"The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in\u00a0vitro and in\u00a0vivo by inhibiting the PI3K\/Akt pathway","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2015.03.011_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cncr.26251","article-title":"FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in\u00a0vitro and in\u00a0vivo","volume":"118","author":"Fang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2015.03.011_bib38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1521-6934(03)00092-0","article-title":"The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN)","volume":"17","author":"Newlands","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:43:46Z","timestamp":1617234226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944015002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0002944015002023"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.03.011","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K\/Akt Signaling","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}